RMTINasdaqPharmaceutical PreparationsFiscal year ends December 31
ROCKWELL MEDICAL, INC.
Financials through Q2 FY2026, quarter ended Jun 30, 2026Last filing: 10-Q on Aug 13, 2026
$7.49+0.06 (+0.81%)
Close on Oct 19, 2026
- Market cap
- $29.65M
- P/E (TTM)
- –
- Dividend yield
- –
Share price
−$4.21 (−35.98%)past year
Daily closes, adjusted for splits. Drag across the chart to measure a change.EarningsSplit
ROCKWELL MEDICAL, INC. saw revenue fall 21.1% to $69.39M over the twelve months to Jun 30, 2026. Free cash flow was $1.54M, down 42.6% from a year earlier.
Revenue
$69.39M
-21.1% vs. a year earlier
Operating income
-$4.52M
TTM Q2 2026
Free cash flow
$1.54M
-42.6% vs. a year earlier
EPS, diluted
-$1.38
TTM Q2 2026
Key statistics
Valuation at the latest close; fundamentals over the trailing twelve months, balances at Jun 30, 2026
Valuation
- Market cap
- $29.65M
- P/E ratio
- –
- Price to sales
- 0.43
- Price to book
- 0.85
- Dividend yield
- –
- Free cash flow yield
- 5.19%
Fundamentals
- Revenue
- $69.39M
- Net income
- -$5.08M
- EPS, diluted
- -$1.38
- Free cash flow
- $1.54M
- Book value per share
- $8.86
- Diluted shares
- 4M
Fifteen years at a glance
Fiscal years 2011 to 2025 and trailing twelve months, USD
Revenue
$69.39M-21.1% YoY
Gross profit
$12.29M-20.3% YoY
Operating income
-$4.52M
Net income
-$5.08M
EPS, diluted
-$1.38
Free cash flow
$1.54M-42.6% YoY
Reported periodTrailing twelve months